← Catalyst calendarMIST biotech catalysts & pipeline
MILESTONE PHARMACEUTICALS INC · Data as of 2026-09-08
Upcoming catalysts
CARDAMYST (etripamil) — Regulatory decision
H1 2027
Regulatory review of the marketing authorization application for etripamil for PSVT in Europe remains on track for a decision from the European Medicines Agency (EMA) in the first half of 2027.
Source filingetripamil nasal spray — Regulatory decision
Q1 2027
A decision on approval is expected by the first quarter of 2027.
Source filingetripamil nasal spray — Regulatory decision
H1 2027
A European decision on approval is expected by the first half of 2027.
Source filingExplore the free biotech catalyst calendar